Increase in gestational diabetes rates linked largely to screening
Gestational diabetes has been reported to be on the rise, but a new study from British Columbia found that changes in screening practices explain much of the increase…. read more.
Gestational diabetes has been reported to be on the rise, but a new study from British Columbia found that changes in screening practices explain much of the increase…. read more.
New research shows that patients with newly diagnosed type 2 diabetes who received treatment with the diabetes drug pioglitazone were less likely to go on to develop dementia… read more.
A review of clinical trials has found that higher vitamin D intake was associated with a 15 percent decreased likelihood for developing type 2 diabetes in adults with… read more.
New research, funded by Hope Against Cancer and published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]) shows that cancer mortality in people with… read more.
A large clinical study is now beginning on an approved drug for treating psoriasis. The drug will be tested on patients who were recently diagnosed with type 1… read more.
Persons with Type 2 diabetes have achieved complete remission of disease following use of an intermittent fasting diet intervention, researchers reported on Dec. 22, 2022 in the Journal… read more.
For the millions of people living with diabetes, insulin is a life-saving drug. Unlike many other medicines, though, insulin cannot be easily delivered by swallowing a pill —… read more.
One type of bacteria found in the gut may contribute to the development of Type 2 diabetes, while another may protect from the disease, according to early results… read more.
Metformin use appears to lower the risk of total joint replacement in patients with type 2 diabetes. Researchers reported this finding on December 19, 2022 in the CMAJ/Canadian… read more.
After an intermittent fasting diet intervention, patients achieved complete diabetes remission, defined as an HbA1c (average blood sugar) level of less than 6.5% at least one year after… read more.
Researchers from a new meta-analysis of data report that, in addition to its known benefits, sodium glucose co-transporter-2 inhibitor (SGLT2) treatment reduces the risk of adverse kidney and… read more.
Martin Hewison, Professor of Molecular Endocrinology at the University of Birmingham. For the past 30 years he has been engaged in research into vitamin D ranging from molecular… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.